Search for: "SANOFI-PHARMACEUTICALS, INC." Results 61 - 80 of 214
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2016, 5:09 pm by Kevin LaCroix
Sanofi,1 the Second Circuit interpreted and applied for the first time the Supreme Court’s decision in Omnicare Inc. v. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
17 May 2020, 2:57 am by Anastasiia Kyrylenko
Kat Friend Matt Swinn shed light on a complex case between the Commonwealth of Australia and the pharmaceutical manufacturer Sanofi. [read post]
10 May 2011, 4:24 pm by Aaron Barkoff
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess… [read post]
3 Nov 2010, 7:00 am
Walters On October 25, Amphastar Pharmaceuticals, Inc. [read post]
19 May 2023, 9:45 am by Eric M. Fraser
Justice Neil Gorsuch wrote for a unanimous court in Amgen Inc. v. [read post]
19 Oct 2010, 8:05 pm
On the same day as FDA's decision, FDA approved a generic Ambien CR® 6.25 mg tablet (tentative approval for 12 mg tablet) filed by Actavis and tentative approvals for generic Ambien CR® 6.25 mg and 12 mg tablets filed by Synthon Pharmaceuticals, Inc. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
21 May 2010, 2:32 am by gmlevine
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]